This is a news story, published by CNBC, that relates primarily to Glen Tullman news.
For more Glen Tullman news, you can click here:
more Glen Tullman newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from CNBC, you can click here:
more news from CNBCOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Other notable FDA approvals. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest other notable medications news, new treatments news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
deadly liver diseaseCNBC
•
84% Informative
The U.S. Food and Drug Administration wrapped up 2024 with 50 new drug approvals.
There were several firsts and other notable medications that the agency gave a green light last year .
Many of the FDA approvals were for products from little known public and private companies, such as Allecra Therapeutics and BridgeBio Pharma.
Transcarent CEO Glen Tullman previously helmed Livongo , which was acquired by Teladoc in a 2020 agreement that valued the company at $18.5 billion .
"We're creating now an experience that people don't just like, they actually love," he said.
VR Score
84
Informative language
85
Neutral language
24
Article tone
formal
Language
English
Language complexity
58
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
7
Affiliate links
no affiliate links